BDTX
Price
$4.01
Change
-$0.17 (-4.07%)
Updated
Oct 17 closing price
Capitalization
228.31M
23 days until earnings call
SRRK
Price
$27.94
Change
-$1.50 (-5.10%)
Updated
Oct 17 closing price
Capitalization
2.69B
30 days until earnings call
Interact to see
Advertisement

BDTX vs SRRK

Header iconBDTX vs SRRK Comparison
Open Charts BDTX vs SRRKBanner chart's image
Black Diamond Therapeutics
Price$4.01
Change-$0.17 (-4.07%)
Volume$875.57K
Capitalization228.31M
Scholar Rock Holding
Price$27.94
Change-$1.50 (-5.10%)
Volume$4.95M
Capitalization2.69B
BDTX vs SRRK Comparison Chart in %
View a ticker or compare two or three
VS
BDTX vs. SRRK commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Hold and SRRK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (BDTX: $4.01 vs. SRRK: $27.94)
Brand notoriety: BDTX and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 91% vs. SRRK: 182%
Market capitalization -- BDTX: $228.31M vs. SRRK: $2.69B
BDTX [@Biotechnology] is valued at $228.31M. SRRK’s [@Biotechnology] market capitalization is $2.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • BDTX’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, BDTX is a better buy in the long-term than SRRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 3 TA indicator(s) are bullish while SRRK’s TA Score has 4 bullish TA indicator(s).

  • BDTX’s TA Score: 3 bullish, 5 bearish.
  • SRRK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SRRK is a better buy in the short-term than BDTX.

Price Growth

BDTX (@Biotechnology) experienced а -1.96% price change this week, while SRRK (@Biotechnology) price change was -29.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

BDTX is expected to report earnings on Nov 10, 2025.

SRRK is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($2.69B) has a higher market cap than BDTX($228M). BDTX YTD gains are higher at: 87.383 vs. SRRK (-35.354). BDTX has higher annual earnings (EBITDA): 5.05M vs. SRRK (-320.22M). SRRK has more cash in the bank: 295M vs. BDTX (143M). BDTX has less debt than SRRK: BDTX (20.8M) vs SRRK (61.5M). BDTX has higher revenues than SRRK: BDTX (70M) vs SRRK (0).
BDTXSRRKBDTX / SRRK
Capitalization228M2.69B8%
EBITDA5.05M-320.22M-2%
Gain YTD87.383-35.354-247%
P/E Ratio16.71N/A-
Revenue70M0-
Total Cash143M295M48%
Total Debt20.8M61.5M34%
FUNDAMENTALS RATINGS
SRRK: Fundamental Ratings
SRRK
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDTXSRRK
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APHNX18.320.15
+0.83%
Artisan Select Equity Institutional
TIOHX17.700.13
+0.74%
Nuveen International Opps I
HAVGX26.890.04
+0.15%
Haverford Quality Growth Stock
GCTMX15.82N/A
N/A
Goldman Sachs International T/M Eq C
JVLCX24.10-0.02
-0.08%
JHancock Disciplined Value C

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with RLAY. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-4.07%
RLAY - BDTX
56%
Loosely correlated
-0.31%
NRIX - BDTX
49%
Loosely correlated
-1.89%
CGEM - BDTX
47%
Loosely correlated
-10.13%
IMCR - BDTX
47%
Loosely correlated
+0.09%
CRBU - BDTX
47%
Loosely correlated
-1.50%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with NUVL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-5.10%
NUVL - SRRK
48%
Loosely correlated
+2.32%
IMNM - SRRK
45%
Loosely correlated
-4.97%
NRIX - SRRK
45%
Loosely correlated
-1.89%
CRNX - SRRK
43%
Loosely correlated
-1.75%
BDTX - SRRK
42%
Loosely correlated
-4.07%
More